Ken Griffin acquired 439 Thousand Theravance Biopharma shares worth $4.85 Million. That's 0.00% of their equity portfolio (1660th largest holding). The first Theravance Biopharma trade was made in Q2 2014. Since then Ken Griffin bought shares 34 more times and sold shares on 36 occasions. The stake costed the investor $4.13 Million, netting the investor a gain of 17% so far.